PortfoliosLab logoPortfoliosLab logo
L.TO vs. HIMS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

L.TO vs. HIMS - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Loblaw Companies Limited (L.TO) and Hims & Hers Health, Inc. (HIMS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

L.TO is traded in CAD, while HIMS is traded in USD. To make them comparable, the HIMS values have been converted to CAD using the latest available exchange rates.

Returns By Period

In the year-to-date period, L.TO achieves a 2.62% return, which is significantly lower than HIMS's 6.91% return.


L.TO

1D
-1.11%
1M
3.42%
YTD
2.62%
6M
2.89%
1Y
15.10%
3Y*
34.35%
5Y*
33.11%
10Y*
26.65%

HIMS

1D
-4.94%
1M
45.31%
YTD
6.91%
6M
-1.64%
1Y
-45.95%
3Y*
62.55%
5Y*
28.27%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

L.TO vs. HIMS - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
L.TO
Loblaw Companies Limited
2.62%34.69%54.55%13.67%21.98%76.92%1.32%-5.59%
HIMS
Hims & Hers Health, Inc.
6.91%28.15%194.69%35.54%4.06%-55.16%43.98%0.07%

Correlation

The correlation between L.TO and HIMS is -0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.01

Correlation (5Y)
Calculated over the trailing 5-year period

0.01

Correlation (All Time)
Calculated using the full available price history since Sep 13, 2019

0.02

Fundamentals

Market Cap

L.TO:

CA$74.67B

HIMS:

$7.66B

EPS

L.TO:

CA$3.72

HIMS:

-$0.05

PS Ratio

L.TO:

0.73

HIMS:

3.47

PB Ratio

L.TO:

6.85

HIMS:

17.17

Total Revenue (TTM)

L.TO:

CA$64.25B

HIMS:

$2.37B

Gross Profit (TTM)

L.TO:

CA$19.91B

HIMS:

$1.70B

EBITDA (TTM)

L.TO:

CA$7.21B

HIMS:

$16.04M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

L.TO vs. HIMS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

L.TO
L.TO Risk / Return Rank: 6262
Overall Rank
L.TO Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
L.TO Sortino Ratio Rank: 5858
Sortino Ratio Rank
L.TO Omega Ratio Rank: 5757
Omega Ratio Rank
L.TO Calmar Ratio Rank: 6464
Calmar Ratio Rank
L.TO Martin Ratio Rank: 6565
Martin Ratio Rank

HIMS
HIMS Risk / Return Rank: 2222
Overall Rank
HIMS Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
HIMS Sortino Ratio Rank: 2525
Sortino Ratio Rank
HIMS Omega Ratio Rank: 2525
Omega Ratio Rank
HIMS Calmar Ratio Rank: 1919
Calmar Ratio Rank
HIMS Martin Ratio Rank: 2121
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

L.TO vs. HIMS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loblaw Companies Limited (L.TO) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


L.TOHIMSDifference
Sharpe ratioReturn per unit of total volatility

+1.19

Sortino ratioReturn per unit of downside risk

+1.30

Omega ratioGain probability vs. loss probability

1.14

0.97

+0.16

Calmar ratioReturn relative to maximum drawdown

1.04

-0.59

+1.63

Martin ratioReturn relative to average drawdown

2.43

-0.96

+3.39

L.TO vs. HIMS - Sharpe Ratio Comparison

The current L.TO Sharpe Ratio is 0.72, which is higher than the HIMS Sharpe Ratio of -0.47. The chart below compares the historical Sharpe Ratios of L.TO and HIMS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

L.TO vs. HIMS - Drawdown Comparison

The maximum L.TO drawdown since its inception was -44.67%, smaller than the maximum HIMS drawdown of -87.01%. Use the drawdown chart below to compare losses from any high point for L.TO and HIMS.


Loading charts...

Drawdown Indicators


L.TOHIMSDifference

Max Drawdown

Largest peak-to-trough decline

-44.67%

-87.01%

+42.34%

Max Drawdown (1Y)

Largest decline over 1 year

-14.53%

-78.30%

+63.77%

Max Drawdown (3Y)

Largest decline over 3 years

-14.53%

-79.64%

+65.11%

Max Drawdown (5Y)

Largest decline over 5 years

-14.53%

-79.64%

+65.11%

Max Drawdown (10Y)

Largest decline over 10 years

-18.54%

Current Drawdown

Current decline from peak

-8.06%

-51.26%

+43.20%

Average Drawdown

Average peak-to-trough decline

-7.05%

-43.10%

+36.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.22%

48.63%

-42.41%

Volatility

L.TO vs. HIMS - Volatility Comparison

The current volatility for Loblaw Companies Limited (L.TO) is 6.47%, while Hims & Hers Health, Inc. (HIMS) has a volatility of 23.35%. This indicates that L.TO experiences smaller price fluctuations and is considered to be less risky than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


L.TOHIMSDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.47%

23.35%

-16.88%

Volatility (6M)

Calculated over the trailing 6-month period

16.19%

69.38%

-53.19%

Volatility (1Y)

Calculated over the trailing 1-year period

21.21%

97.86%

-76.65%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.94%

83.83%

-64.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

20.39%

77.76%

-57.37%

Dividends

L.TO vs. HIMS - Dividend Comparison

L.TO's dividend yield for the trailing twelve months is around 0.91%, while HIMS has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
HIMS
Hims & Hers Health, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
L.TO
Loblaw Companies Limited
0.91%2.19%4.20%5.43%5.28%5.40%8.15%7.40%6.45%7.84%7.27%7.61%

Financials

L.TO vs. HIMS - Financials Comparison

This section allows you to compare key financial metrics between Loblaw Companies Limited and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B20222023202420252026
14.48B
608.10M
(L.TO) Total Revenue
(HIMS) Total Revenue
Please note, different currencies. L.TO values in CAD, HIMS values in USD

L.TO vs. HIMS - Profitability Comparison

The chart below illustrates the profitability comparison between Loblaw Companies Limited and Hims & Hers Health, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
31.3%
65.3%
Portfolio components
L.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Loblaw Companies Limited reported a gross profit of 4.54B and revenue of 14.48B. Therefore, the gross margin over that period was 31.3%.

HIMS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.

L.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Loblaw Companies Limited reported an operating income of 1.01B and revenue of 14.48B, resulting in an operating margin of 7.0%.

HIMS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.

L.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Loblaw Companies Limited reported a net income of 594.00M and revenue of 14.48B, resulting in a net margin of 4.1%.

HIMS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.


Frequently Asked Questions


L.TO and HIMS have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for L.TO and HIMS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer